glucose, (beta-d)-isomer has been researched along with Pulmonary Consumption in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, PB | 1 |
| Cron, J | 3 |
| Ashman, J; Bekker, LG; Bilek, N; Coler, RN; Day, TA; Diacon, A; Du Plessis, N; Fiore-Gartland, A; Frevol, A; Geldenhuys, H; Hatherill, M; Lindestam Arlehamn, C; Loxton, AG; Luabeya, AKK; Mabwe, S; Penn-Nicholson, A; Reed, SG; Reid, TD; Rolf, TA; Sagawa, ZK; Scriba, TJ; Sette, A; Shenje, J; Tameris, M; Toefy, A; Vergara, J; Walzl, G | 1 |
| EHLERT, H | 1 |
1 trial(s) available for glucose, (beta-d)-isomer and Pulmonary Consumption
| Article | Year |
|---|---|
Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Antibodies, Bacterial; Antitubercular Agents; Dose-Response Relationship, Immunologic; Double-Blind Method; Female; Glucosides; Humans; Immunogenicity, Vaccine; Lipid A; Male; Middle Aged; Mycobacterium tuberculosis; Recurrence; Secondary Prevention; Tuberculosis Vaccines; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Young Adult | 2021 |
5 other study(ies) available for glucose, (beta-d)-isomer and Pulmonary Consumption
| Article | Year |
|---|---|
Defective leukotaxis in monocytes from patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Chemotaxis, Leukocyte; Chronic Disease; Dose-Response Relationship, Immunologic; Ethambutol; Female; Humans; Immunity, Cellular; In Vitro Techniques; Isoniazid; Lung Diseases; Lymphokines; Male; Middle Aged; Monocytes; Rifampin; Tuberculosis, Pulmonary; Zymosan | 1979 |
The influence of stimulation with Zymosan on the total complement level in lung cancer and tuberculosis.
Topics: Antigen-Antibody Reactions; Complement System Proteins; Cytotoxicity Tests, Immunologic; Humans; Lung Neoplasms; Regression Analysis; Stimulation, Chemical; Tuberculosis, Pulmonary; Zymosan | 1973 |
A contribution to the role of properdin in anticancer defence of the organism.
Topics: Humans; Lung Neoplasms; Properdin; Silicosis; Time Factors; Tuberculosis, Pulmonary; Zymosan | 1970 |
Response of host organism on Zymosan application. (A clinical study).
Topics: Diagnosis, Differential; Humans; Injections, Intramuscular; Lung Neoplasms; Properdin; Silicosis; Tuberculosis, Pulmonary; Zymosan | 1970 |
[PAS glucoside as an infusion solution in the treatment of cavernous pulmonary tuberculosis and tuberculous meningitis].
Topics: Aminosalicylic Acids; Glucosides; Humans; Infusions, Parenteral; Pharmaceutical Solutions; Tuberculosis; Tuberculosis, Meningeal; Tuberculosis, Pulmonary | 1954 |